Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 455

1.

Applications of decellularized extracellular matrix in bone and cartilage tissue engineering.

Kim YS, Majid M, Melchiorri AJ, Mikos AG.

Bioeng Transl Med. 2018 Oct 26;4(1):83-95. doi: 10.1002/btm2.10110. eCollection 2019 Jan. Review.

2.

Progress in three-dimensional printing with growth factors.

Koons GL, Mikos AG.

J Control Release. 2019 Feb 10;295:50-59. doi: 10.1016/j.jconrel.2018.12.035. Epub 2018 Dec 20.

PMID:
30579982
3.

Three-dimensional Printing of Multilayered Tissue Engineering Scaffolds.

Bittner SM, Guo JL, Melchiorri A, Mikos AG.

Mater Today (Kidlington). 2018 Oct;21(8):861-874. doi: 10.1016/j.mattod.2018.02.006. Epub 2018 Mar 20.

PMID:
30450010
4.

Increased recruitment of endogenous stem cells and chondrogenic differentiation by a composite scaffold containing bone marrow homing peptide for cartilage regeneration.

Lu J, Shen X, Sun X, Yin H, Yang S, Lu C, Wang Y, Liu Y, Huang Y, Yang Z, Dong X, Wang C, Guo Q, Zhao L, Sun X, Lu S, Mikos AG, Peng J, Wang X.

Theranostics. 2018 Oct 5;8(18):5039-5058. doi: 10.7150/thno.26981. eCollection 2018.

5.

Multimaterial Segmented Fiber Printing for Gradient Tissue Engineering.

Diaz-Gomez L, Smith BT, Kontoyiannis PD, Bittner SM, Melchiorri AJ, Mikos AG.

Tissue Eng Part C Methods. 2019 Jan;25(1):12-24. doi: 10.1089/ten.TEC.2018.0307. Epub 2018 Dec 28.

PMID:
30421648
6.

A high-strength mineralized collagen bone scaffold for large-sized cranial bone defect repair in sheep.

Wang S, Zhao Z, Yang Y, Mikos AG, Qiu Z, Song T, Cui F, Wang X, Zhang C.

Regen Biomater. 2018 Oct;5(5):283-292. doi: 10.1093/rb/rby020. Epub 2018 Aug 13.

7.

Biomechanical forces in tissue engineered tumor models.

Chim LK, Mikos AG.

Curr Opin Biomed Eng. 2018 Jun;6:42-50. doi: 10.1016/j.cobme.2018.03.004. Epub 2018 Mar 26.

PMID:
30276358
8.

Reverse transduction can improve efficiency of AAV vectors in transduction-resistant cells.

Lee EJ, Robinson TM, Tabor JJ, Mikos AG, Suh J.

Biotechnol Bioeng. 2018 Dec;115(12):3042-3049. doi: 10.1002/bit.26830. Epub 2018 Oct 1.

PMID:
30199099
9.

Microfluidic devices for disease modeling in muscle tissue.

Smoak MM, Pearce HA, Mikos AG.

Biomaterials. 2018 Aug 30. pii: S0142-9612(18)30619-7. doi: 10.1016/j.biomaterials.2018.08.059. [Epub ahead of print]

PMID:
30193908
10.

Immunosuppressed Adult Zebrafish Model of Mucormycosis.

Tatara AM, Wurster S, Lockworth CR, Albert ND, Walsh TJ, Mikos AG, Eisenhoffer GT, Kontoyiannis DP.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e00698-18. doi: 10.1128/AAC.00698-18. Print 2018 Nov. No abstract available.

PMID:
30150461
11.

Incorporation of fast dissolving glucose porogens and poly(lactic-co-glycolic acid) microparticles within calcium phosphate cements for bone tissue regeneration.

Smith BT, Lu A, Watson E, Santoro M, Melchiorri AJ, Grosfeld EC, van den Beucken JJJP, Jansen JA, Scott DW, Fisher JP, Mikos AG.

Acta Biomater. 2018 Sep 15;78:341-350. doi: 10.1016/j.actbio.2018.07.054. Epub 2018 Aug 1.

PMID:
30075321
12.

An Overview of the Tissue Engineering Market in the United States from 2011 to 2018.

Kim YS, Smoak MM, Melchiorri AJ, Mikos AG.

Tissue Eng Part A. 2019 Jan;25(1-2):1-8. doi: 10.1089/ten.TEA.2018.0138. Epub 2018 Sep 4.

PMID:
30027831
13.

Injectable OPF/graphene oxide hydrogels provide mechanical support and enhance cell electrical signaling after implantation into myocardial infarct.

Zhou J, Yang X, Liu W, Wang C, Shen Y, Zhang F, Zhu H, Sun H, Chen J, Lam J, Mikos AG, Wang C.

Theranostics. 2018 May 12;8(12):3317-3330. doi: 10.7150/thno.25504. eCollection 2018.

14.

Material Processing and Design of Biodegradable Metal Matrix Composites for Biomedical Applications.

Yang J, Guo JL, Mikos AG, He C, Cheng G.

Ann Biomed Eng. 2018 Sep;46(9):1229-1240. doi: 10.1007/s10439-018-2058-y. Epub 2018 Jun 4. Review.

PMID:
29869105
15.

Econazole-releasing porous space maintainers for fungal periprosthetic joint infection.

Tatara AM, Rozich AJ, Kontoyiannis PD, Watson E, Albert ND, Bennett GN, Mikos AG.

J Mater Sci Mater Med. 2018 May 11;29(5):70. doi: 10.1007/s10856-018-6073-1.

PMID:
29752591
16.

Large Animal Models of an In Vivo Bioreactor for Engineering Vascularized Bone.

Akar B, Tatara AM, Sutradhar A, Hsiao HY, Miller M, Cheng MH, Mikos AG, Brey EM.

Tissue Eng Part B Rev. 2018 Aug;24(4):317-325. doi: 10.1089/ten.TEB.2018.0005. Epub 2018 Apr 12.

PMID:
29471732
17.

Drug delivery and tissue engineering to promote wound healing in the immunocompromised host: Current challenges and future directions.

Tatara AM, Kontoyiannis DP, Mikos AG.

Adv Drug Deliv Rev. 2018 Apr;129:319-329. doi: 10.1016/j.addr.2017.12.001. Epub 2017 Dec 6. Review.

PMID:
29221962
18.

Application of Materials as Medical Devices with Localized Drug Delivery Capabilities for Enhanced Wound Repair.

Lee EJ, Huh BK, Kim SN, Lee JY, Park CG, Mikos AG, Choy YB.

Prog Mater Sci. 2017 Aug;89:392-410. doi: 10.1016/j.pmatsci.2017.06.003. Epub 2017 Jun 13.

19.

A review on the exploitation of biodegradable magnesium-based composites for medical applications.

Yang J, Koons GL, Cheng G, Zhao L, Mikos AG, Cui F.

Biomed Mater. 2018 Jan 9;13(2):022001. doi: 10.1088/1748-605X/aa8fa0.

PMID:
28954931
20.

Multimodal pore formation in calcium phosphate cements.

Lodoso-Torrecilla I, van Gestel NAP, Diaz-Gomez L, Grosfeld EC, Laperre K, Wolke JGC, Smith BT, Arts JJ, Mikos AG, Jansen JA, Hofmann S, van den Beucken JJJP.

J Biomed Mater Res A. 2018 Feb;106(2):500-509. doi: 10.1002/jbm.a.36245. Epub 2017 Oct 27.

PMID:
28940662
21.

Selective laser sintering scaffold with hierarchical architecture and gradient composition for osteochondral repair in rabbits.

Du Y, Liu H, Yang Q, Wang S, Wang J, Ma J, Noh I, Mikos AG, Zhang S.

Biomaterials. 2017 Aug;137:37-48. doi: 10.1016/j.biomaterials.2017.05.021. Epub 2017 May 12.

22.

Synthesis and Characterization of Diol-Based Unsaturated Polyesters: Poly(diol fumarate) and Poly(diol fumarate-co-succinate).

Tatara AM, Watson E, Satish T, Scott DW, Kontoyiannis DP, Engel PS, Mikos AG.

Biomacromolecules. 2017 Jun 12;18(6):1724-1735. doi: 10.1021/acs.biomac.7b00044. Epub 2017 May 17.

PMID:
28486802
23.

Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999-2015.

Heo ST, Tatara AM, Jiménez-Ortigosa C, Jiang Y, Lewis RE, Tarrand J, Tverdek F, Albert ND, Verweij PE, Meis JF, Mikos AG, Perlin DS, Kontoyiannis DP.

Clin Infect Dis. 2017 Jul 15;65(2):216-225. doi: 10.1093/cid/cix297.

24.

Honing Cell and Tissue Culture Conditions for Bone and Cartilage Tissue Engineering.

Lam J, Lee EJ, Clark EC, Mikos AG.

Cold Spring Harb Perspect Med. 2017 Dec 1;7(12). pii: a025734. doi: 10.1101/cshperspect.a025734. Review.

PMID:
28348176
25.

3D printing for the design and fabrication of polymer-based gradient scaffolds.

Bracaglia LG, Smith BT, Watson E, Arumugasaamy N, Mikos AG, Fisher JP.

Acta Biomater. 2017 Jul 1;56:3-13. doi: 10.1016/j.actbio.2017.03.030. Epub 2017 Mar 22. Review.

26.

3D printing PLGA: a quantitative examination of the effects of polymer composition and printing parameters on print resolution.

Guo T, Holzberg TR, Lim CG, Gao F, Gargava A, Trachtenberg JE, Mikos AG, Fisher JP.

Biofabrication. 2017 Apr 12;9(2):024101. doi: 10.1088/1758-5090/aa6370.

27.

Extrusion-based 3D printing of poly(propylene fumarate) scaffolds with hydroxyapatite gradients.

Trachtenberg JE, Placone JK, Smith BT, Fisher JP, Mikos AG.

J Biomater Sci Polym Ed. 2017 Apr;28(6):532-554. doi: 10.1080/09205063.2017.1286184. Epub 2017 Feb 5.

28.

Effects of Local Antibiotic Delivery from Porous Space Maintainers on Infection Clearance and Induction of an Osteogenic Membrane in an Infected Bone Defect.

Shah SR, Smith BT, Tatara AM, Molina ER, Lee EJ, Piepergerdes TC, Uhrig BA, Guldberg RE, Bennett GN, Wenke JC, Mikos AG.

Tissue Eng Part A. 2017 Feb;23(3-4):91-100. doi: 10.1089/ten.TEA.2016.0389. Epub 2017 Jan 11.

29.

Incorporation of fast dissolving glucose porogens into an injectable calcium phosphate cement for bone tissue engineering.

Smith BT, Santoro M, Grosfeld EC, Shah SR, van den Beucken JJJP, Jansen JA, Mikos AG.

Acta Biomater. 2017 Mar 1;50:68-77. doi: 10.1016/j.actbio.2016.12.024. Epub 2016 Dec 10.

PMID:
27956363
30.

Modeling Stroma-Induced Drug Resistance in a Tissue-Engineered Tumor Model of Ewing Sarcoma.

Santoro M, Menegaz BA, Lamhamedi-Cherradi SE, Molina ER, Wu D, Priebe W, Ludwig JA, Mikos AG.

Tissue Eng Part A. 2017 Jan;23(1-2):80-89. doi: 10.1089/ten.TEA.2016.0369.

31.

Fond Memories of our Mentor J. David Hellums, Annals of Biomedical Engineering.

Simon SI, Mikos AG, McIntire LV.

Ann Biomed Eng. 2016 Nov;44(11):3157. No abstract available.

PMID:
27783234
32.

Reconstruction of large mandibular defects using autologous tissues generated from in vivo bioreactors.

Tatara AM, Shah SR, Demian N, Ho T, Shum J, van den Beucken JJJP, Jansen JA, Wong ME, Mikos AG.

Acta Biomater. 2016 Nov;45:72-84. doi: 10.1016/j.actbio.2016.09.013. Epub 2016 Sep 12.

PMID:
27633319
33.

A composite critical-size rabbit mandibular defect for evaluation of craniofacial tissue regeneration.

Shah SR, Young S, Goldman JL, Jansen JA, Wong ME, Mikos AG.

Nat Protoc. 2016 Oct;11(10):1989-2009. doi: 10.1038/nprot.2016.122. Epub 2016 Sep 22.

PMID:
27658014
34.

IGF-1R and mTOR Blockade: Novel Resistance Mechanisms and Synergistic Drug Combinations for Ewing Sarcoma.

Lamhamedi-Cherradi SE, Menegaz BA, Ramamoorthy V, Vishwamitra D, Wang Y, Maywald RL, Buford AS, Fokt I, Skora S, Wang J, Naing A, Lazar AJ, Rohren EM, Daw NC, Subbiah V, Benjamin RS, Ratan R, Priebe W, Mikos AG, Amin HM, Ludwig JA.

J Natl Cancer Inst. 2016 Aug 30;108(12). pii: djw182. doi: 10.1093/jnci/djw182. Print 2016 Dec.

35.

Acellular mineral deposition within injectable, dual-gelling hydrogels for bone tissue engineering.

Vo TN, Tatara AM, Santoro M, van den Beucken JJ, Leeuwenburgh SC, Jansen JA, Mikos AG.

J Biomed Mater Res A. 2017 Jan;105(1):110-117. doi: 10.1002/jbm.a.35875. Epub 2016 Sep 21.

PMID:
27557993
36.

Tissue Engineering in Orthopaedics.

Tatara AM, Mikos AG.

J Bone Joint Surg Am. 2016 Jul 6;98(13):1132-9. doi: 10.2106/JBJS.16.00299. Review.

37.

Factors affecting patient outcome in primary cutaneous aspergillosis.

Tatara AM, Mikos AG, Kontoyiannis DP.

Medicine (Baltimore). 2016 Jun;95(26):e3747. doi: 10.1097/MD.0000000000003747. Review.

38.

Effects of cellular parameters on the in vitro osteogenic potential of dual-gelling mesenchymal stem cell-laden hydrogels.

Vo TN, Tabata Y, Mikos AG.

J Biomater Sci Polym Ed. 2016 Aug;27(12):1277-90. doi: 10.1080/09205063.2016.1195157.

39.

Poly(lactic acid) nanofibrous scaffolds for tissue engineering.

Santoro M, Shah SR, Walker JL, Mikos AG.

Adv Drug Deliv Rev. 2016 Dec 15;107:206-212. doi: 10.1016/j.addr.2016.04.019. Epub 2016 Apr 26. Review.

40.

Data describing the swelling behavior and cytocompatibility of biodegradable polyelectrolyte hydrogels incorporating poly(L-lysine) for applications in cartilage tissue engineering.

Lam J, Clark EC, Fong EL, Lee EJ, Lu S, Tabata Y, Mikos AG.

Data Brief. 2016 Mar 4;7:614-9. doi: 10.1016/j.dib.2016.02.077. eCollection 2016 Jun.

41.

Evaluation of Gelatin Microparticles as Adherent-Substrates for Mesenchymal Stem Cells in a Hydrogel Composite.

Lu S, Lee EJ, Lam J, Tabata Y, Mikos AG.

Ann Biomed Eng. 2016 Jun;44(6):1894-907. doi: 10.1007/s10439-016-1582-x. Epub 2016 Mar 2.

42.

Evaluation of cell-laden polyelectrolyte hydrogels incorporating poly(L-Lysine) for applications in cartilage tissue engineering.

Lam J, Clark EC, Fong EL, Lee EJ, Lu S, Tabata Y, Mikos AG.

Biomaterials. 2016 Mar;83:332-46. doi: 10.1016/j.biomaterials.2016.01.020. Epub 2016 Jan 7.

43.

Injectable dual-gelling cell-laden composite hydrogels for bone tissue engineering.

Vo TN, Shah SR, Lu S, Tatara AM, Lee EJ, Roh TT, Tabata Y, Mikos AG.

Biomaterials. 2016 Mar;83:1-11. doi: 10.1016/j.biomaterials.2015.12.026. Epub 2015 Dec 31.

44.

2015 Lifetime Achievement Award of Tissue Engineering and Regenerative Medicine International Society-Americas: Antonios G. Mikos, PhD.

Tatara AM, Mikos AG.

Tissue Eng Part A. 2016 Jan;22(1-2):1-2. doi: 10.1089/ten.tea.2015.29000.agm. Epub 2015 Dec 18. No abstract available.

PMID:
26682734
45.

A 3D in vitro model of patient-derived prostate cancer xenograft for controlled interrogation of in vivo tumor-stromal interactions.

Fong EL, Wan X, Yang J, Morgado M, Mikos AG, Harrington DA, Navone NM, Farach-Carson MC.

Biomaterials. 2016 Jan;77:164-72. doi: 10.1016/j.biomaterials.2015.10.059. Epub 2015 Nov 9.

46.

Bone Tissue Engineering Challenges in Oral & Maxillofacial Surgery.

Smith BT, Shum J, Wong M, Mikos AG, Young S.

Adv Exp Med Biol. 2015;881:57-78. doi: 10.1007/978-3-319-22345-2_4.

PMID:
26545744
47.

Novel applications of statins for bone regeneration.

Shah SR, Werlang CA, Kasper FK, Mikos AG.

Natl Sci Rev. 2015 Mar 1;2(1):85-99. Epub 2014 Aug 16.

48.

The Maturation of Tissue Engineering.

Mikos AG, Johnson PC, Fisher JP, Jansen JA.

Tissue Eng Part A. 2015 Oct;21(19-20):2473-5. doi: 10.1089/ten.tea.2015.0398. Epub 2015 Sep 24. No abstract available.

PMID:
26402224
49.

A rapid, flexible method for incorporating controlled antibiotic release into porous polymethylmethacrylate space maintainers for craniofacial reconstruction.

Mountziaris PM, Shah SR, Lam J, Bennett GN, Mikos AG.

Biomater Sci. 2016 Jan;4(1):121-9. doi: 10.1039/c5bm00175g.

50.

Immunomodulatory properties of stem cells and bioactive molecules for tissue engineering.

Molina ER, Smith BT, Shah SR, Shin H, Mikos AG.

J Control Release. 2015 Dec 10;219:107-118. doi: 10.1016/j.jconrel.2015.08.038. Epub 2015 Aug 22. Review.

PMID:
26307349

Supplemental Content

Loading ...
Support Center